Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem
cell research. Submissions covering all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem
cells, developmental studies, stem cell genomes, and translational research, are encouraged.
Presubmission inquiries are encouraged.
Acceptance of manuscripts will be based on scientific excellence and priority, as judged by editors and reviewers, on relevance to the
central themes of the journal, and on the interest of the results to a broad readership of stem cell biology. A manuscript of high intrinsic
quality may be returned if it seems better suited to a more specialized journal. Manuscripts that present preliminary observations or
an incremental increase in understanding are not encouraged.
Submission of Manuscripts
Submission to this journal proceeds
totally online via the Stem Cell Research Web sit at http://ees.elsevier.com/scr.Use the following guidelines
to prepare your article. All correspondence, including notification of the Editor's decision and requests for revision, takes place by
e-mail and via the author's homepage, removing the need for a hard-copy paper trail.
Authors are encouraged to suggest four competent
reviewers in their field (please include telephone number, fax number, and/or e-mail address for potential reviewers) and may also suggest
individuals whom they wish to have excluded from the review process.
Acceptable file types. Once a paper is accepted, Stem
Cell Research cannot use PDF or PostScript files because they do not allow editing of the text. Most word-processing packages are
acceptable; however, we prefer that authors use a recent version of Microsoft Word or WordPerfect. Submit each figure as a separate TIFF,
EPS, or JPEG file.
Terms. Original papers only will be considered. Manuscripts are accepted for review on the understanding
that the same work has not been published, that it is not under consideration for publication elsewhere, and that its submission for
publication has been approved by all of the authors and by the appropriate authority at the institution where the work was carried out.
Authors must verify the wording of any cited personal communication with the persons who supplied the information and obtain approval
for the use of their names in connection with the quoted information or for the citation of unpublished work; written evidence of such
approval should accompany the manuscript. All material published in represents the opinions of the authors and should not be construed
to reflect the opinions of the Editors or the Publisher.
Upon acceptance of an article, authors will be asked to sign a "Journal
Publishing Agreement (for more information on this and copyright see www.elsevier.com/wps/find/authorshome.authors/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the
corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form.
If material from
other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s)
in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Oxford, UK: phone
(+44) 1865 843830, fax (+44) 1865 853333, e-mail: permissions@elsevier.com. Requests may also be completed online via
www.elsevier.com/locate/permissions.
Regular articles. Regular articles should not exceed 55,000 characters
(including spaces, references, methods, figure legends, and an abstract of 200 words or less). We accept a maximum of 7 figures/tables
for regular articles.
Short reports. Articles intended for the Short Report section of Stem Cell Research should
not exceed 32,000 characters (including spaces, references, methods, figures, and an abstract of 200 words or less). Brief reports may
contain a maximum of 4 figures/tables.
Review articles.Stem Cell Research also publishes review articles, which
as for regular articles should be limited to 55,000 characters. Stem Cell Research does not accept unsolicited review articles
unless they are preapproved by the Editor-in-Chief. All review articles will be subject to review before publication.
Communications.
Stem Cell Research welcomes descriptions of major new initiatives, policies and consortia news related to stem cells. These are published
at the discretion of the Editors. Communications should not exceed 32,000 characters (including spaces, references, and figures.) They
should not include an abstract.
Methods and Reagents. The journal publishes articles describing novel methods and/or reagents.
These may take the form of regular articles or short reports.
Any article type may contain supplementary material to be published
online.
Preparation of Manuscripts
Manuscripts should be written in clear, concise, grammatical English and be double-spaced
throughout. Pages should be numbered consecutively and organized as follows:
The Title Page (p. 1) should contain the article
title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail
address and telephone and fax numbers).
The Abstract (p. 2) must be a single paragraph that summarizes the main findings
of the paper in less than 200 words (no references). After the abstract a list of up to 10 keywords that will be useful for indexing
or searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials
and methods should be sufficiently detailed to enable the experiments to be reproduced. Detailed methods should be supplied as supplementary
data.
Results and Discussion should be organized into subheadings. In Brief Reports, subheadings are optional.
Acknowledgments
should be brief and should precede the references.
References to the literature should be cited by name and date in the
text and listed in alphabetical order at the end. Use the most recent edition of the Chemical Abstracts Service Source Index for abbreviations
of journal titles.
Text: All citations in the text should refer to:
1. Single author: The authors name (without
initials, unless there is ambiguity) and the year of publication.
2. Two authors: Both authors names and the year of publication.
3. Three or more authors: First authors name followed by et al.! and the year of publication.
Citations may be made directly
(or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: as demonstrated
(Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown ...."
List: References should be arranged
first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same
year must be identified by the letters a!,b!,c!, etc., placed after the year of publication.
Examples:
Reference to
a journal publication:
Macias, M.Y., Syring, M.B., Pizzi, M.A., Crowe, M.J., Alexanian, A.R., Kurpad, S.N.,
2006. Pain with no gain:
Allodynia following neural stem cell transplantation in spinal
cord injury. Exp. Neurol. 201, 335-348.
Reference to a book:
Stephanopoulos,
G.N., Aristidou, A.A., Nielsen, J., 1998. Metabolic Engineering:
Principles and Methodologies. Academic Press, San Diego.
Reference
to a chapter in an edited book:
Holleran, E.A., Karki, S., Holzbaur, E.L.F., 1998. The role of the dynactin complex in
intracellular
motility. In: Jeon, K.W. (Ed.), International Review of Cytology. Academic
Press, San Diego, Vol. 182, pp. 69-109.
Figures.
Number figures consecutively with Arabic numerals. Please visit www.elsevier.com/artworkinstructions for detailed instructions
on preparing electronic artwork.
Color figures. If together with your accepted article, you submit usable color figures,
then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other
sites) regardless of whether these illustrations are reproduced in color in the printed version. For color reproduction in print, you
will receive information regarding the costs from Elsevier after receipt of your accepted article. For further information on the preparation
of electronic artwork, please see www.elsevier.com/artworkinstructions
Cover Illustrations. Authors are encouraged
to submit illustrations that may be appropriate as journal cover art. Such illustrations should include an appropriate legend and be
identified as potential cover material. These illustrations must be relevant to the mission of Stem Cell Research. Potential
cover material should be submitted through the Web site as part of your cover letter file.
Tables should be numbered consecutively
with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title
typed directly above and with essential footnotes below.
DNA sequences and GenBank accession numbers. Authors wishing to
enable other scientists to use the accession numbers cited in their papers via links to these sources should type this information in
the following manner: For each and every accession number cited in an article, authors should type the accession number in bold, underlined
text. Letters in the accession number should always be capitalized (see example below). This combination of letters and format will enable
the typesetter to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example:
GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank
accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Authors are encouraged to check accession
numbers used very carefully. An error in a letter or number can result in a dead link. In the final version of the printed article, the
accession number text will not appear bold or underlined. In the final version of the electronic copy, the accession number
text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article.
Preparation of Supplementary Material
Supplementary files offer the author additional possibilities to publish supporting
applications, movies, animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied
will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect. To ensure
that your submitted material is directly usable, please provide data in one of our recommended file formats. Submit the material in electronic
format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions, please visit
our artwork instruction pages at www.elsevier.com/artworkinstructions.
Proofs
PDF proofs will be sent by
e-mail to the corresponding author. To avoid delay in publication, only necessary changes should be made, and corrections should be returned
promptly.
Policy
It is understood that novel biological reagents described in manuscripts accepted for publication in Stem Cell Research, e.g., DNA and antibodies, will be made available to scientists in academic research. All novel genetic sequence
information must be deposited with GenBank or the EMBL database.
Studies Involving Humans and Animals
Manuscripts reporting
on studies involving human subjects must include a statement in the Methods section identifying the committee approving the studies and
confirming that informed consent was obtained from all subjects. Similarly, manuscripts must expressly confirm that all experiments on
live vertebrates or higher invertebrates were performed in accordance with relevant institutional and national guidelines and regulations.
This, along with a statement identifying the committee approving the experiments, should be included in the Methods section. Should concerns
arise regarding human or animal studies, the editors reserve the right to request further information from the authors and may seek additional
comments from reviewers and/or independent experts.
Author Inquiries
For inquiries relating to the submission of articles
(including electronic submission where available) please visit www.elsevier.com/authors. This site also provides the facility
to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork
guidelines, copyright information, frequently asked questions, and more. Contact details for questions arising after acceptance of an
article, especially those relating to proofs, are provided after registration of an article for publication.
Sponsored Articles Stem Cell Research offers authors or their institutions the option to sponsor nonsubscriber access to their articles on Elsevier's
electronic publishing platforms.
Special Subject Repositories
Certain repositories such as PubMed Central ("PMC") are authorized
under special arrangement with Elsevier to process and post certain articles such as those funded by the National Institutes of Health
under its Public Access policy (see elsevier.com for more detail on our policy). Articles accepted for publication in an Elsevier journal
from authors who have indicated that the underlying research reported in their articles was supported by an NIH grant will be sent by
Elsevier to PMC for public access posting 12 months after final publication. The version of the article provided by Elsevier will include
peer-review comments incorporated by the author into the article. Because the NIH 'Public Access' policy is voluntary, authors may elect
not to deposit such articles in PMC. If you wish to 'opt out' and not deposit to PMC, you may indicate this by sending an e-mail to NIHauthorrequest@elsevier.com.
